Marketable Securities

12 Months Ended

Dec. 31, 2021

Marketable Securities

Marketable Securities

7. Marketable Securities

Marketable securities in equity securities with readily determinable market prices consisted of the following as of December 31, 2021 and 2020:

	Marketable equity securities at December 31, 2021
			Gross unrealized		Gross unrealized
	Cost		gains		losses			Fair value
Common shares	$	53,475,000	$	32,000	$	(13,127,000	)	$	40,380,000

	Marketable equity securities at December 31, 2020
			Gross unrealized		Gross unrealized
	Cost		gains		gains losses			Fair value
Common shares	$	1,506,000	$	1,083,000	$	(26,000	)	$	2,563,000

The following table presents additional information about marketable equity securities:

	Marketable
	Equity Securities
Balance at January 1, 2020	$	640,000
Purchases of marketable equity securities		1,425,000
Sales of marketable equity securities		(373,000	)
Realized gains on marketable equity securities		75,000
Unrealized gains on marketable equity securities		796,000
Balance at January 1, 2021		2,563,000
Purchases of marketable equity securities in operations		385,235,000
Purchases of marketable equity securities		2,765,000
Conversion of debt securities to marketable securities		2,656,000
Sales of marketable equity securities in operations		(355,837,000	)
Sales of marketable equity securities		(4,062,000	)
Realized gains on marketable equity securities		27,377,000
Realized losses on marketable equity securities		(6,190,000	)
Unrealized losses on marketable equity securities		(14,127,000	)
Balance at December 31, 2021	$	40,380,000

At December 31, 2021 and 2020, the Company had invested in the marketable equity securities of certain publicly traded companies. The Company’s investment in marketable equity securities will be revalued on each balance sheet date.